Pharmacy Benefit Managers as Pharmaceutical Marketers

Courtesy Health Care Renewal  Tue, 06/16/2009 - 19:00

We posted a number of times about questionable practices Eli Lilly used to market its atypical anti-psychotic drug Zyprexa (olanzapine ).

A post from 2007, with links backward, is here , and our most recent post is here .

The company remains entangled in litigation over its marketing of this drug. That litigation has lead to the release of numerous internal documents that provide quite a view of Lilly's marketing practices. Bloomberg continued its reporting...

Tags:

 

More related items

Express Scripts buying Medco for $29.1B
Share: The two biggest prescription drug benefit managers in the U.S. plan to combine in a $29.1 billion deal they say will help rein in costs and improve patients' health. Express...

Walgreen to hold off selling genetic test kits
WASHINGTON (AP) -- The largest U.S. drugstore chain, Walgreen Co., said Wednesday it will hold off selling what was poised to be the first over-the-counter genetic test, after the Food and...

Omnicare, IVAX Settle
Settlements and kickbacks and corporate integrity agreements, oh my (to the tune of "lions and tigers and bears, oh my")To quote the BusinessWeek version of the story:A $112 million...

Country Save HE Laundry Detergent, Powder, 160-Load,...

Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com